Literature DB >> 21357882

Internet-based cognitive-behavioural therapy for severe health anxiety: randomised controlled trial.

Erik Hedman1, Gerhard Andersson, Erik Andersson, Brjánn Ljótsson, Christian Rück, Gordon J G Asmundson, Nils Lindefors.   

Abstract

BACKGROUND: Hypochondriasis, characterised by severe health anxiety, is a common condition associated with functional disability. Cognitive-behavioural therapy (CBT) is an effective but not widely disseminated treatment for hypochondriasis. Internet-based CBT, including guidance in the form of minimal therapist contact via email, could be a more accessible treatment, but no study has investigated internet-based CBT for hypochondriasis. AIMS: To investigate the efficacy of internet-based CBT for hypochondriasis.
METHOD: A randomised controlled superiority trial with masked assessment comparing internet-based CBT (n = 40) over 12 weeks with an attention control condition (n = 41) for people with hypochondriasis. The primary outcome measure was the Health Anxiety Inventory. This trial is registrated with ClinicalTrials.gov (NCT00828152).
RESULTS: Participants receiving internet-based CBT made large and superior improvements compared with the control group on measures of health anxiety (between-group Cohen's d range 1.52-1.62).
CONCLUSIONS: Internet-based CBT is an efficacious treatment for hypochondriasis that has the potential to increase accessibility and availability of CBT for hypochodriasis.

Entities:  

Mesh:

Year:  2011        PMID: 21357882     DOI: 10.1192/bjp.bp.110.086843

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  37 in total

1.  CHAMP: Cognitive behaviour therapy for health anxiety in medical patients, a randomised controlled trial.

Authors:  Peter Tyrer; Sylvia Cooper; Helen Tyrer; Paul Salkovskis; Mike Crawford; John Green; Georgina Smith; Steven Reid; Simon Dupont; David Murphy; Sarah Byford; Duolao Wang; Barbara Barrett
Journal:  BMC Psychiatry       Date:  2011-06-14       Impact factor: 3.630

Review 2.  Validity of Current Treatment Protocols to Overcome Hypochondriasis.

Authors:  Shrayash Khare; Meher Narain Srivastava
Journal:  J Clin Diagn Res       Date:  2017-01-01

3.  Attention control group activities and perceived benefit in a trial of a behavioral intervention for older adults.

Authors:  Sarah E LaFave; Marianne Granbom; Thomas K M Cudjoe; Alex Gottsch; Gerard Shorb; Sarah L Szanton
Journal:  Res Nurs Health       Date:  2019-10-24       Impact factor: 2.228

4.  Effect of Internet vs Face-to-Face Cognitive Behavior Therapy for Health Anxiety: A Randomized Noninferiority Clinical Trial.

Authors:  Erland Axelsson; Erik Andersson; Brjánn Ljótsson; Daniel Björkander; Maria Hedman-Lagerlöf; Erik Hedman-Lagerlöf
Journal:  JAMA Psychiatry       Date:  2020-09-01       Impact factor: 21.596

Review 5.  Digitally Delivered Psychological Interventions for Anxiety Disorders: a Comprehensive Review.

Authors:  Evgenia Stefanopoulou; David Lewis; Matthew Taylor; James Broscombe; Jan Larkin
Journal:  Psychiatr Q       Date:  2019-03

6.  Sudden gains in internet-based cognitive behaviour therapy for severe health anxiety.

Authors:  Erik Hedman; Mats Lekander; Brjánn Ljótsson; Nils Lindefors; Christian Rück; Stefan G Hofmann; Erik Andersson; Gerhard Andersson; Stefan M Schulz
Journal:  Behav Res Ther       Date:  2014-01-11

7.  Advantages and limitations of Internet-based interventions for common mental disorders.

Authors:  Gerhard Andersson; Nickolai Titov
Journal:  World Psychiatry       Date:  2014-02       Impact factor: 49.548

8.  Treatment of mental hypochondriasis: a case report.

Authors:  Florian Weck
Journal:  Psychiatr Q       Date:  2014-03

Review 9.  Recent Advances in the Understanding and Treatment of Health Anxiety.

Authors:  Peter Tyrer
Journal:  Curr Psychiatry Rep       Date:  2018-06-22       Impact factor: 5.285

10.  Can attention control conditions have detrimental effects on behavioral medicine randomized trials?

Authors:  Sherry L Pagoto; Mary M McDermott; George Reed; Philip Greenland; Kathy M Mazor; Judith K Ockene; Matt Whited; Kristin Schneider; Brad Appelhans; Kathy Leung; Philip Merriam; Ira Ockene
Journal:  Psychosom Med       Date:  2012-11-28       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.